Global Stem Cell Manufacturing Market Research Report 2018 – Increased Market Focus on Embryonic Stem Cells …Markets InsiderThe global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a… Continue reading
South China Morning PostGlobal Stem Cell Manufacturing Market Research Report 2018 – Increased Market Focus on Embryonic Stem Cells …PR Newswire (press release)The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 … Continue reading
South China Morning PostGlobal Stem Cell Manufacturing Market Research Report 2018 – Increased Market Focus on Embryonic Stem Cells …PR Newswire (press release)The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 … Continue reading
Researchers Map Tumor Suppressive Landscape of Lung Cancer in Mice Using CRISPR, Barcode SeqGenomeWebNEW YORK (GenomeWeb) – Researchers at Stanford University and the Massachusetts Institute of Technology used a combination of tumor barcoding, CRISPR-… Continue reading
Stem Cell Manufacturing (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables) Market – Global Forecast to …Business Wire (press release)The growing public-private investments and funding in stem cell-based research, rising public awareness regar… Continue reading
CNBC |
Pfizer signs a deal with Allogene to develop a cancer cell therapy
CNBC Pfizer said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy. The agreement will accelerate the … Pfizer signs deal with Allogene to develop cancer cell therapyReuters Kite founder’s new firm inks off-the-shelf CAR T deal with PfizerBioPharma-Reporter.com Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno …Business Wire (press release) Forbes –STAT all 8 news articles » |